Kimberly A Mollo

Kimberly A Mollo is a seasoned professional in medical writing and regulatory documentation, currently serving as the Director and Team Lead for Medical Writing at Genmab since January 2022. Previously, Kimberly held the position of Senior Director at Bristol Myers Squibb from May 2011 to January 2022, leading medical writing activities in cellular therapy, oncology, and hematology throughout the clinical development cycle. Prior experience includes roles as Manager of Clinical Writing at Merck, where oversight of a ten-member medical writing team occurred, and as Principal Medical Writer at Schering-Plough, where a variety of regulatory documents were prepared. Beginning a career in pharmaceuticals as a Senior Drug Information Specialist at Schering-Plough Research Institute, Kimberly also served as Pharmacist in Charge at CVS Caremark Corporation. Educational qualifications include a Pharm D from the University of Florida and a BS in Pharmacy from the Massachusetts College of Pharmacy and Health Sciences.